United Kingdom (GB)

PET- And SPECT-based navigation strategies to advance procedural accuracy in interventional radiology and image-guided surgery (2021) Boekestijn I, Azargoshasb S, Schilling C, Navab N, Rietbergen D, Van Oosterom MN Journal article, Review article Adversarial interference and its mitigations in privacy-preserving collaborative machine learning (2021) Usynin D, Ziller A, Makowski M, Braren R, Rueckert D, Glocker B, Kaissis G, Passerat-Palmbach J Journal article, Review article The burden of traumatic brain injury from low-energy falls among patients from 18 countries in the CENTER-TBI Registry: A comparative cohort study (2021) Lecky FE, Otesile O, Marincowitz C, Majdan M, Nieboer D, Lingsma HF, Maegele M, et al. Journal article Assessment of the fetal thymus gland: Comparing MRI-acquired thymus volumes with 2D ultrasound measurements (2021) Myers R, Hutter J, Matthew J, Zhang T, Uus A, Lloyd D, Egloff A, et al. Journal article Neural BRDF Representation and Importance Sampling (2021) Sztrajman A, Rainer G, Ritschel T, Weyrich T Journal article An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021) Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al. Conference contribution Clusters of Psoriatic Arthritis Patients at Baseline Based on Different Ultrasound Detected Synovitis: Exploratory Analysis from a Phase III Study (2021) D'Agostino MA, Schett G, Gaillez C, Conaghan P, Naredo E, Carron P, Burgos-Vargas R, et al. Conference contribution Guselkumab (TREMFYA (R)) Maintains Resolution of Dactylitis and Enthesitis in Patients with Active Psoriatic Arthritis: Results Through 2 Years from a Phase 3 Study (2021) Rahman P, Mcinnes I, Deodhar A, Schett G, Mease P, Shawi M, Cua D, et al. Conference contribution Ultrasound Demonstrates Continued Improvement in Psoriatic Arthritis Synovitis and Enthesitis with Secukinumab: 52-week Results from a Phase III Study (2021) D'Agostino MA, Schett G, Gaillez C, Guerrero C, Hanova P, Cazenave T, Stoenoiu MS, et al. Conference contribution Bimekizumab in Patients with Psoriatic Arthritis: 3-Year Results for Overall and Tumor Necrosis Factor Inhibitor (TNFi)-Naive Populations from a Phase 2b Open-Label Extension Study (2021) Mease P, Deodhar A, Merola J, Mcinnes I, Assudani D, Bajracharya R, Coarse J, et al. Conference contribution